Central Nervous System Neoplasms D016543

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Nervous System Neoplasms » Central Nervous System Neoplasms

Diseases [C] » Nervous System Diseases [C10] » Nervous System Neoplasms » Central Nervous System Neoplasms

Description

Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.   MeSH

Hierarchy View

Subtype Terms (4)

Brain Neoplasms
524 drugs (252 approved, 272 experimental)

Central Nervous System Cysts
 

Meningeal Neoplasms
8 drugs (5 approved, 3 experimental)

Spinal Cord Neoplasms
15 drugs (10 approved, 5 experimental)


Other Experimental Indicated Drugs (3)


Organization Involved with Phase 4 Indications (3)

Organization Involved with Phase 3 Indications (59)

Organization Involved with Phase 2 Indications (102)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.